
Researchers identify Sirt1 as target in aggressive prostate cancer
A new study points to Sirt1 as a driver of neuroendocrine prostate cancer and suggests that blocking it could slow or prevent tumor growth.
- A Columbia-led study identified Sirt1 as a driver of neuroendocrine prostate cancer.
- Blocking Sirt1 prevented NEPC tumor growth in mice.




